OBJECTIVE: 1) Identify key clinical, biochemical, cytological and sonographic predictors of malignancy in cytologically indeterminate thyroid nodule. 2) Quantify the risk of malignancy using a formula derived from regression analysis.
patients, initially treated at our institution, are counted twice). Neck dissections consisted of levels II-V in 36 (46%), , and I-V in 14 (18%) necks. The remaining 13 (17%) necks were dissected at a single level (nϭ8) or multiple levels (nϭ5) not noted above. Among all necks treated, metastatic adenopathy was confirmed pathologically as follows: 2.6% level I, 38% level II, 45% level III, 47% level IV, and 17% level V. Comparing primary and recurrent disease, there was no difference in nodal distribution for levels I-III. Level IV was positive in 33% of primary and 60% of recurrent groups (pϭ0.04). Level V was positive in 14% of primary and 19% of recurrent groups (pϭ0.70). Adjuvant I-131 was given in 30 (97%) primary cases and 14 (38 %) recurrent cases. At median follow-up of 37 (1-120) months, neck control was seen in 76 (97%) with only one recurrence (99% control) within a previously operated neck level. CONCLUSION: Neck dissection in PTC gives excellent control of regional disease. Based on the pathologic distribution of nodes, dissection should routinely include levels II-IV with attention and inclusion of level V based on imaging and intra-operative findings. Routine level I dissection is not necessary.
Management Challenges in Supernumerary Parathyroid Adenoma
Jason Showmaker, BS (presenter); Matthew Page, MD; Jeffrey Jorgensen, MD; Robert P. Zitsch III, MD OBJECTIVE: 1) To present the management difficulties when primary hyperparathyroidism is complicated by mediastinal adenoma in a supernumerary parathyroid gland (SPG), and 2) To offer the authors' considerations for the management of this situation based on this experience and a literature review. METHOD: An individual patient's clinical records were examined, and the pertinent literature was reviewed. RESULTS: We describe a case of primary hyperparathyroidism in a 60 year old male with critically elevated iCa of 2.09mmol/L and iPTH of 1164pg/mL. Preoperative localization studies were negative. A left superior adenoma was identified intraoperatively; however, the ten-minute post-excision rapid intraoperative PTH level paradoxically increased from preoperative baseline. Examination of the remaining glands revealed diffuse hyperplasia, and the patient underwent fourgland removal with 1/2 gland autotransplantation. There was minimal reduction of iPTH to 761pg/mL. The presence of a hyperfunctioning SPG was suspected and a comprehensive exploration of acknowledged ectopic locations failed to identify a fifth gland. Postoperatively, hyperparathyroidism persisted, and an MRI revealed an 18mm mass in the superior mediastinum which was excised via sternotomy and proved to be a second adenoma. The iPTH declined to normal range, and normocalcemia has persisted after a follow-up period of six months.
CONCLUSION:
This case of persistent hyperparathyroidism after three 1/2-gland parathyroidectomy was caused by a second adenoma in a mediastinal SPG that eluded preoperative imaging and a careful neck exploration. It serves to enlighten parathyroid surgeons of the impact of SPGs and to offer considerations for their challenging management.
Management of Advanced Thyroid Malignancy
Kamrul Hasan Tarafder, MBBS, FCPS, FICS (presenter); Pran Gopal Datta; Hasanur Rahman Nasima Akhtar OBJECTIVE: To see the effectiveness of the management of advanced thyroid cancer according to the protocol used in the otolaryngology department of BSM Medical University. METHOD: Non-randomized prospective study on advanced cases of thyroid malignancy were marked on the basis of extracapsular spread/Local invasion, regional &/or distal metastasis during a period of seven years (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) . RESULTS: Two-hundred and fifty-nine consecutive cases of thyroid malignancy were treated within the study period. Papillary & Follicular carcinoma formed the main bulk (89%). About 54% cases presented at an advanced stage. Among the advanced cases 82% presented with lymphatic metastasis, skeletal (sternum, skull, ribs, jaw or femur), pulmonary & brain metastasis were found in 5%, 12% and 1.5% respectively. Local invasion to trachea, larynx, pharynx or esophagus was found in 12.23% cases, fixity to great vessels in neck and recurrent laryngeal nerve involvement was found in 6.47% & 15.51% cases. In 6.47% cases no definitive treatment could be offered. Surgery (92%) and radioiodine ablation (86%) were mainstay of treatment; external beam radiation was used in 4% cases. Perioperative mortality was seen in 5 cases. Cases were followed up for a mean period of 5.2 years; 30.40% cases were lost to follow up. Among the respondents mortality was 19.54% and recurrence was seen in 25% cases. CONCLUSION: With definitive treatment of advanced thyroid carcinoma there is a high chance of recurrence which is again treatable in most of the cases. The mortality is also much higher than that of early thyroid malignancy. nodules with pre-op FNAC diagnosis of follicular lesion or neoplasm. Clinical, biochemical (TSH, thyroglobulin), cytological and sonographic parameters were collected. Univariate and multivariate analyses were conducted. RESULTS: Significant correlations found in cytologic nuclear groove (OR 4.73, 95% CI 1.51 14.78, Pϭ0.005) and atypia (OR 7.82, 95% CI 1.59 38.51, Pϭ0.004), sonographic microcalcification (OR 5.50, 95% CI 1.02 29.71, Pϭ0.029) and macrocalcification (OR 4.21, 95% CI 1.28 13.78, Pϭ0.012) by univariate analysis. The mean level of serum TSH was 50% higher in malignant group although failed to achieve statistical significance. Macrocalcification was the only factor showing correlation in binary logistic regression analysis (AOR 4.06, 95% CI 1.06 15.53, Pϭ0.041). The formula calculating the probability of malignancy was derived [Probability ϭ 1/(1ϩe-Z); Z ϭ -2.56 ϩ 1.12*(nuclear groove) ϩ 1.20*(atypia) ϩ 0.81*(microcalcification) ϩ 1.40*(macrocalcification) ϩ 0.21*(TSH) , factor present ϭ 1 , absence ϭ 0, TSH level/ (mIU/L)]. Sensitivity and specificity for malignancy were 84.2% and 61.8% respectively when using a cut-off probability at 10.0% in the ROC curve. CONCLUSION: This study showed nuclear groove, atypia and sonographic calcification were statistically significant predictors for thyroid malignancy. The risk stratification formula was useful supplement for the operative decision.
Methods of Detecting HPV in Oropharyngeal Carcinoma
David Smith, PhD (presenter); Jean Lewis, MD; Jan Kasperbauer, MD; Rebecca Laborde, PhD OBJECTIVE: 1) Understand methods of HPV detection in Head and Neck Squamous Cell Carcinoma. 2) Be able to compare three methods HPV detection in oropharyngeal carcinoma: HPV DNA detection using polymerase chain reaction (PCR) in fresh frozen and formalin-fixed paraffin embedded (FFPE) tissue samples and p16 immunostaining. METHOD: DNA was extracted from oropharyngeal fresh frozen and FFPE tumor samples of 33 patients. This was analyzed for presence of HPV DNA by PCR using the L1 universal primers MY09 and MY11 and a specific primer set to the HPV 16 E6 region. The HPV DNA positive samples than underwent immunostaining analysis of p16INK4a. RESULTS: 78% of the fresh frozen samples were HPV positive using the L1 universal and the HPV 16 E6 specific primers. 76% of the FFPE samples were HPV positive using the E6 specific primers. 60% of the FFPE samples were HPV positive using the L1 universal primers. Of the HPV DNA positive fresh frozen samples, 76% were p16 positive. In the p16 positive samples, surrounding normal tissue was negative for p16 in all cases. CONCLUSION: 78% of the fresh frozen samples were HPV positive using the L1 universal and the HPV 16 E6 specific primers. 76% of the FFPE samples were HPV positive using the E6 specific primers. 60% of the FFPE samples were HPV positive using the L1 universal primers. Of the HPV DNA positive fresh frozen samples, 76% were p16 positive. In the p16 positive samples, surrounding normal tissue was negative for p16 in all cases.
Microsurgery for Acoustic Neuroma after Radiation Failure
Richard Wiet, MD (presenter); Joyce Kim; Robert Battista, MD; Robert Kazan, MD OBJECTIVE: To review the results of microsurgery for acoustic neuroma after radiation failure. METHOD: A database of patients with the diagnosis of acoustic neuroma was reviewed retrospectively. Patients with neurofibromatosis type 2 were excluded. A study group was identified of six patients who had microsurgery after radiation that fit the inclusion criteria. RESULTS: Fifty percent of the patients received LINAC radiotherapy and the remaining patients received gamma knife radiosurgery. The mean marginal radiation dose was 15.75 Gy. The mean time period between radiation and microsurgical resection was 27 months. The average pre-microsurgery tumor size was 2.4 cm. All six patients underwent translabyrinthine resection of their tumor. Indications for microsurgical resection were: growth of tumor (4 patients) and disabling hemifacial spasm (2 patients). The mean follow up period was 19.5 months. All patients had normal facial function prior to microsurgery. At the time of microsurgery, five of the six tumors were found to have increased adherence of the tumor to the facial nerve relative to nonirradiated tumors. One patient required facial nerve anastomosis at the time of surgery and one patient required a cranial nerve 12 to 7 jump graft. At last follow up, facial function was as follows: 2 patients with House-Brackmann grade I, 1 grade II, 1 grade III, 1 grade V, and VI. CONCLUSION: Microsurgery after radiation is often more challenging, and facial nerve results are commonly worse, compared to microsurgery for nonirradiated tumors.
MMP-9 Analysis in Carcinogen-Treated Oral Keratinocytes
Beverly Wuertz (presenter); Frank Ondrey, MD, PhD OBJECTIVE: 1) Determine baseline expression of matrix metalloproteinases in oral precancerous cell lines. 2) Analyze the effect of cigarette smoke condensate on expression of MMP-9 gene and functional protein in transformed keratinocytes. METHOD: Cultures of oral keratinocytes (Rhek), oral leukoplakia (MSK-Leuk1), and oral squamous cell carcinoma (CA-9-22) were seeded at one million cells per flask and grown for
